Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma
作者： Yangyang Wang , Francesco Sabbatino , Xinhui Wang , Soldano Ferrone
DOI: 10.1007/978-1-62703-727-3_28
关键词: Antibody 、 Cancer research 、 Tumor antigen 、 CSPG4 、 Antigen 、 Melanoma 、 Immunotherapy 、 Chondroitin Sulfate Proteoglycan 4 、 Immunohistochemistry 、 Chemistry
摘要: The tumor antigen chondroitin sulfate proteoglycan 4 (CSPG4) appears to be a useful biomarker identify melanoma cells and an attractive target apply antibody-based immunotherapy for the treatment of melanoma. Here we described reverse transcription-polymerase chain reaction (RT-PCR) method immunohistochemical (IHC) staining detect expression CSPG4 in tissues.
springer.com
unisa.it参考文章(26)
Carolyn G. Marsden, Mary Jo Wright, Radhika Pochampally, Brian G. Rowan, Breast Tumor-Initiating Cells Isolated from Patient Core Biopsies for Study of Hormone Action Methods in Molecular Biology. ,vol. 590, pp. 363- 375 ,(2009) , 10.1007/978-1-60327-378-7_23
Michael Campoli, Soldano Ferrone, Xinhui Wang, Functional and clinical relevance of chondroitin sulfate proteoglycan 4. Advances in Cancer Research. ,vol. 109, pp. 73- 121 ,(2010) , 10.1016/B978-0-12-380890-5.00003-X
S Ferrone, M Kusama, Z J Chen, T Kageshita, Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies. Journal of Immunology. ,vol. 143, pp. 3844- 3852 ,(1989)
Jeanette H W Leusen, Peter Boross, Mechanisms of action of CD20 antibodies American Journal of Cancer Research. ,vol. 2, pp. 676- 690 ,(2012)
Toshiro Kageshita, Soldano Ferrone, Zhi Jian Chen, Hong Yang, Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371. Cancer Research. ,vol. 51, pp. 4790- 4797 ,(1991)
Wei Luo, Jeff Chi-feng Hsu, Chun-Yen Tsao, Eric Ko, Xinhui Wang, Soldano Ferrone, Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities. Journal of Immunology. ,vol. 174, pp. 7104- 7110 ,(2005) , 10.4049/JIMMUNOL.174.11.7104
Federico Perosa, Soldano Ferrone, Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA-DR,DP monoclonal antibody CR11-462 Human Immunology. ,vol. 23, pp. 255- 269 ,(1988) , 10.1016/0198-8859(88)90061-4
Raphael Clynes, Antitumor antibodies in the treatment of cancer: Fc receptors link opsonic antibody with cellular immunity. Hematology-oncology Clinics of North America. ,vol. 20, pp. 585- 612 ,(2006) , 10.1016/J.HOC.2006.02.010
Carlos L. Arteaga, Mark X. Sliwkowski, C. Kent Osborne, Edith A. Perez, Fabio Puglisi, Luca Gianni, Treatment of HER2-positive breast cancer: current status and future perspectives Nature Reviews Clinical Oncology. ,vol. 9, pp. 16- 32 ,(2012) , 10.1038/NRCLINONC.2011.177
Parthasarathy Seshacharyulu, Moorthy P Ponnusamy, Dhanya Haridas, Maneesh Jain, Apar K Ganti, Surinder K Batra, Targeting the EGFR signaling pathway in cancer therapy Expert Opinion on Therapeutic Targets. ,vol. 16, pp. 15- 31 ,(2012) , 10.1517/14728222.2011.648617